Plain-English translation of NCT06915753 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 1 โ Testing in a small group (usually 20โ80 people) to find a safe dose and watch for side effects.
This is one of the first times this treatment has been tested in people.
This is an early-stage trial testing a new drug called in people with advanced liver cancer or other solid tumors that have certain genetic changes related to cancer growth. Researchers want to find the right dose of this medication and see how well it works to shrink tumors and help patients. The trial is one of the first studies of this drug in humans.
Some cancers grow because of specific genetic changes that turn on growth signals in tumor cells. This medication is designed to block those growth signals, which may help slow or stop cancer growth in people whose other treatments have not worked.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
The trial has different phases: first, researchers test increasing doses of the medication to find the safest and most effective dose, then larger groups of patients take the medication at that dose. You would take the medication by mouth regularly and visit the clinic for blood tests, scans, and check-ups to see how the cancer responds and monitor for side effects. The trial is open-ended, meaning you can continue taking the medication as long as it is helping and you are tolerating it well.
AI-generated summary from trial data ยท Aug 15, 2026 ยท Not medical advice
United States